Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.94 is 85% below its 5-year average of 6.20, near the low end of its 5-year range (0.94–24.43).
As of the fiscal period ended Tuesday, June 30, 2026. 25.20% below its 12-month average of 1.25.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.94.
QUICK RATIO (ACID-TEST)
0.94
QUICK RATIO (ACID-TEST) AVG TTM
1.25
QUICK RATIO (ACID-TEST) AVG 3Y
2.15
QUICK RATIO (ACID-TEST) AVG 5Y
6.20
QUICK RATIO (ACID-TEST) AVG 10Y
4.33
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-25.20%
CURRENT VS 3Y AVG
-56.45%
CURRENT VS 5Y AVG
-84.90%
CURRENT VS 10Y AVG
-78.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
-68.67%
vs the sector median at left
Moleculin Biotech, Inc.
Market Cap
$2.40M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.25
3Y Avg
2.15
5Y Avg
6.20
Market Cap
$2.36M
Quick Ratio (Acid-Test)
1.54
TTM Avg
2.65
3Y Avg
3.41
5Y Avg
4.73
Market Cap
$2.32M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.27M
Quick Ratio (Acid-Test)
2.14
TTM Avg
0.35
3Y Avg
1.93
5Y Avg
12.75
Market Cap
$2.54M
Quick Ratio (Acid-Test)
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.56M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$2.67M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.70
3Y Avg
0.81
5Y Avg
0.98
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moleculin Biotech, Inc. (MBRX) | $2.40M | 0.94 | 1.25 | 2.15 | 6.20 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | 1.54 | 2.65 | 3.41 | 4.73 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.73 | 22.34 | 19.49 | 14.70 |
| Onconetix, Inc. (ONCO)vs › | $2.27M | 2.14 | 0.35 | 1.93 | 12.75 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | 2.64 | 2.37 | 1.52 | 1.27 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.56M | 1.41 | 1.72 | 3.92 | 2.64 |
| iSpecimen Inc. (ISPC)vs › | $2.63M | 0.82 | 0.87 | 1.93 | 3.50 |
| Nuwellis, Inc. (NUWE)vs › | $2.64M | 1.54 | 1.94 | 2.53 | 3.69 |
| Jaguar Health, Inc. (JAGX)vs › | $2.67M | 0.40 | 0.70 | 0.81 | 0.98 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | 4.85 | 5.04 | 6.52 | 9.62 |
Quick Ratio
0.94
Excludes inventory
Current Ratio
0.94
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.94 |
| 2026-03-31 | 1.38 |
| 2025-12-31 | 1.41 |
| 2025-09-30 | 1.39 |
| 2025-06-30 | 1.15 |
| 2025-03-31 | 1.35 |
| 2024-12-31 | 0.97 |
| 2024-09-30 | 2.08 |
| 2024-06-30 | 2.39 |
| 2024-03-31 | 3.51 |
| 2023-12-31 | 3.86 |
| 2023-09-30 | 7.10 |
| 2023-06-30 | 5.40 |
| 2023-03-31 | 7.81 |
| 2022-12-31 | 9.46 |
| 2022-09-30 | 8.41 |
| 2022-06-30 | 10.47 |
| 2022-03-31 | 13.91 |
| 2021-12-31 | 20.02 |
| 2021-09-30 | 21.08 |
| 2021-06-30 | 24.43 |
| 2021-03-31 | 19.23 |
| 2020-12-31 | 5.89 |
| 2020-09-30 | 4.44 |
| 2020-06-30 | 5.28 |
| 2020-03-31 | 4.26 |
| 2019-12-31 | 3.78 |
| 2019-09-30 | 1.44 |
| 2019-06-30 | 2.11 |
| 2019-03-31 | 1.49 |
| 2018-12-31 | 2.06 |
| 2018-09-30 | 2.99 |
| 2018-06-30 | 3.13 |
| 2018-03-31 | 7.64 |
| 2017-12-31 | 3.75 |
| 2017-09-30 | 5.17 |
| 2017-06-30 | 5.51 |
| 2017-03-31 | 4.15 |
| 2016-12-31 | 3.88 |
| 2016-09-30 | 5.02 |
| 2016-06-30 | 5.39 |
| 2016-03-31 | 0.33 |
| 2015-09-30 | 0.33 |
